These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23761899)

  • 21. Lineage tracing reveals dynamic changes in oligodendrocyte precursor cells following cuprizone-induced demyelination.
    Baxi EG; DeBruin J; Jin J; Strasburger HJ; Smith MD; Orthmann-Murphy JL; Schott JT; Fairchild AN; Bergles DE; Calabresi PA
    Glia; 2017 Dec; 65(12):2087-2098. PubMed ID: 28940645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative temporal changes in DTI values coupled with histological properties in cuprizone-induced demyelination and remyelination.
    Yano R; Hata J; Abe Y; Seki F; Yoshida K; Komaki Y; Okano H; Tanaka KF
    Neurochem Int; 2018 Oct; 119():151-158. PubMed ID: 29030079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Remyelination After Cuprizone-Induced Demyelination Is Accelerated in Juvenile Mice.
    Pfeifenbring S; Nessler S; Wegner C; Stadelmann C; Brück W
    J Neuropathol Exp Neurol; 2015 Aug; 74(8):756-66. PubMed ID: 26115190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Receptor tyrosine phosphatase beta (RPTPbeta) activity and signaling are attenuated by glycosylation and subsequent cell surface galectin-1 binding.
    Abbott KL; Matthews RT; Pierce M
    J Biol Chem; 2008 Nov; 283(48):33026-35. PubMed ID: 18838383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyroid hormone alleviates demyelination induced by cuprizone through its role in remyelination during the remission period.
    Zhang M; Zhan XL; Ma ZY; Chen XS; Cai QY; Yao ZX
    Exp Biol Med (Maywood); 2015 Sep; 240(9):1183-96. PubMed ID: 25577802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic effect of oligomeric proanthocyanidin in cuprizone-induced demyelination.
    Wang Q; Wang J; Yang Z; Sui R; Miao Q; Li Y; Yu J; Liu C; Zhang G; Xiao B; Ma C
    Exp Physiol; 2019 Jun; 104(6):876-886. PubMed ID: 30811744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. G-Protein-Coupled Receptor Gpr17 Expression in Two Multiple Sclerosis Remyelination Models.
    Nyamoya S; Leopold P; Becker B; Beyer C; Hustadt F; Schmitz C; Michel A; Kipp M
    Mol Neurobiol; 2019 Feb; 56(2):1109-1123. PubMed ID: 29873041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acid sphingomyelinase deficiency enhances myelin repair after acute and chronic demyelination.
    Chami M; Halmer R; Schnoeder L; Anne Becker K; Meier C; Fassbender K; Gulbins E; Walter S
    PLoS One; 2017; 12(6):e0178622. PubMed ID: 28582448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting TrkB with a Brain-Derived Neurotrophic Factor Mimetic Promotes Myelin Repair in the Brain.
    Fletcher JL; Wood RJ; Nguyen J; Norman EML; Jun CMK; Prawdiuk AR; Biemond M; Nguyen HTH; Northfield SE; Hughes RA; Gonsalvez DG; Xiao J; Murray SS
    J Neurosci; 2018 Aug; 38(32):7088-7099. PubMed ID: 29976621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet-derived growth factor promotes repair of chronically demyelinated white matter.
    Vana AC; Flint NC; Harwood NE; Le TQ; Fruttiger M; Armstrong RC
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):975-88. PubMed ID: 17984680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The K
    Albrecht S; Korr S; Nowack L; Narayanan V; Starost L; Stortz F; Araúzo-Bravo MJ; Meuth SG; Kuhlmann T; Hundehege P
    Glia; 2019 May; 67(5):870-883. PubMed ID: 30623969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tropomyosin Receptor Kinase B Expressed in Oligodendrocyte Lineage Cells Functions to Promote Myelin Following a Demyelinating Lesion.
    Huang Y; Song YJ; Isaac M; Miretzky S; Patel A; Geoffrey McAuliffe W; Dreyfus CF
    ASN Neuro; 2020; 12():1759091420957464. PubMed ID: 32927995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cuprizone model: regional heterogeneity of pathology.
    Wergeland S; Torkildsen Ø; Myhr KM; Mørk SJ; Bø L
    APMIS; 2012 Aug; 120(8):648-57. PubMed ID: 22779688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abcd1 deficiency accelerates cuprizone-induced oligodendrocyte loss and axonopathy in a demyelinating mouse model of X-linked adrenoleukodystrophy.
    Martinović K; Bauer J; Kunze M; Berger J; Forss-Petter S
    Acta Neuropathol Commun; 2023 Jun; 11(1):98. PubMed ID: 37331971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Astrocyte-targeted production of interleukin-6 reduces astroglial and microglial activation in the cuprizone demyelination model: Implications for myelin clearance and oligodendrocyte maturation.
    Petković F; Campbell IL; Gonzalez B; Castellano B
    Glia; 2016 Dec; 64(12):2104-2119. PubMed ID: 27535761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Astroglial-derived lymphotoxin-alpha exacerbates inflammation and demyelination, but not remyelination.
    Plant SR; Arnett HA; Ting JP
    Glia; 2005 Jan; 49(1):1-14. PubMed ID: 15382206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of Galectin-3: From Oligodendroglial Differentiation and Myelination to Demyelination and Remyelination Processes in a Cuprizone-Induced Demyelination Model.
    Hoyos HC; Marder M; Ulrich R; Gudi V; Stangel M; Rabinovich GA; Pasquini LA; Pasquini JM
    Adv Exp Med Biol; 2016; 949():311-332. PubMed ID: 27714696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unconventional Myosin ID is Involved in Remyelination After Cuprizone-Induced Demyelination.
    Yamazaki R; Baba H; Yamaguchi Y
    Neurochem Res; 2018 Jan; 43(1):195-204. PubMed ID: 28986688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amyloid precursor protein and amyloid precursor-like protein 2 have distinct roles in modulating myelination, demyelination, and remyelination of axons.
    Truong PH; Ciccotosto GD; Merson TD; Spoerri L; Chuei MJ; Ayers M; Xing YL; Emery B; Cappai R
    Glia; 2019 Mar; 67(3):525-538. PubMed ID: 30506868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Astrocyte-specific expression of a soluble form of the murine complement control protein Crry confers demyelination protection in the cuprizone model.
    Briggs DT; Martin CB; Ingersoll SA; Barnum SR; Martin BK
    Glia; 2007 Nov; 55(14):1405-15. PubMed ID: 17674370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.